Provenance du réseau au premier degré de Patrick Loustau
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 73 | |
| Public Company | Pharmaceuticals: Major | 67 | |
| Extinct | Biotechnology | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Patrick Loustau via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| NNIT A/S | Information Technology Services | Director/Board Member Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | President Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Chairman Director/Board Member Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member President | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Director/Board Member | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Aarhus | College/University | Graduate Degree Director/Board Member Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Chairman Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
| AMBRX INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Undergraduate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| St Bartholomew's Hospital Medical College | College/University | Doctorate Degree Graduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CATALENT, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Indian Institute of Technology Roorkee | College/University | Graduate Degree Undergraduate Degree | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| AVROBIO, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Indiana University | College/University | Graduate Degree Undergraduate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal Doctorate Degree | |
| Bristol-Myers Squibb Foundation | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 28 |
| Danemark | 14 |
| Royaume-Uni | 4 |
| Suède | 3 |
| Israël | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 17 |
| Finance | 3 |
| Technology Services | 2 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 503 |
| Corporate Officer/Principal | 286 |
| Independent Dir/Board Member | 158 |
| Chairman | 145 |
| Chief Tech/Sci/R&D Officer | 103 |
Relations les plus connectées
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Göran Albert Ando | 44 |
| Jack Nielsen | 38 |
| Thomas Daniel | 35 |
| Robert Perez | 31 |
| Dinesh C. Paliwal | 31 |
| Sten Scheibye | 31 |
| Jesper Brandgaard | 28 |
| Steen Riisgaard | 24 |
| Peter Helt Jacobsen Haahr | 21 |
| Frances K. Heller | 21 |
| Leif Valdemar Johansson | 21 |
| Thomas Lynch | 20 |
| Hannu Ragnvald Ryöppönen | 20 |
| Charles Sigal | 20 |
- Bourse
- Insiders
- Patrick Loustau
- Connexions Sociétés
